Erasca ERAS
NASDAQ ERAS
$14.49 -0.13 (-0.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Erasca (ERAS) Receivables - Other (2021 - 2022)

Updated

Erasca's Receivables - Other was $100,000 in Q3 2022, unchanged from the prior quarter.

Analysis

Erasca (ERAS) Receivables - Other (2021 - 2022) Analysis & Trends

From Q4 2021 onward, Erasca has reported Receivables - Other for 4 quarters.

  • Per Business Quant data, ERAS's Receivables - Other in the three quarters before Q3 2022 was $100,000 (Q2 2022), $100,000 (Q1 2022) and $100,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Erasca 4.52 Bn 3.44 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 100,000.00
Jun 30, 2022 100,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 100,000.00
API Access

Erasca Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ERAS&period=max&api_key=YOUR_API_KEY